Recent News

• 09.15.2025 - Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
• 09.11.2025 - Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
• 09.10.2025 - Avidity Biosciences Announces Proposed Public Offering of Common Stock
• 09.10.2025 - Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD44

Recent Filings

• 09.12.2025 - EX-99.1 EX-99.1
• 09.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.12.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 09.12.2025 - 8-K Current report
• 09.11.2025 - 144 Report of proposed sale of securities
• 09.10.2025 - EX-99.1 EX-99.1
• 09.10.2025 - 8-K Current report
• 09.10.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 09.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.05.2025 - 4 Statement of changes in beneficial ownership of securities